News Focus
News Focus
Followers 33
Posts 4311
Boards Moderated 0
Alias Born 07/16/2014

Re: blu_1 post# 1246

Monday, 02/27/2017 10:30:33 AM

Monday, February 27, 2017 10:30:33 AM

Post# of 21574
--------------
"The problem with Neurotrope is that is doesn't address the cause of Alzeimers, ...."
---------------


I strongly suggest that you view (or review) the following presentation.

https://www.veracast.com/webcasts/bio/ceoinvestor2017/18111483071.cfm?0.593469021981


They weren't even targeting plaques, their removal was an unexpected result. Perhaps this approach will reveal the " missing link" behind the root causes of A-beta and Tau that is truly the correct upstream target.

"Neurotrope Bioscience’s lead Alzheimer’s drug candidate, bryostatin, promotes the formation of new synapses in the brains of mice, according to the study, “PKC epsilon Promotes Synaptogenesis through Membrane accumulation of the Postsynaptic Density Protein PSD-95,” recently published in the Journal of Biological Chemistry."

https://alzheimersnewstoday.com/2016/07/05/neurotrope-announces-new-study-published-journal-biological-chemistry-shows-bryostatin-pkc-epsilon-activator-generates-new-synapses-accumulation-synaptic-anch/




Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TAOX News